Immunology & inflammation R&D trends and breakthrough innovations
Providing scientific decision-makers with a roadmap of high-impact I&I opportunities, emerging technologies, and potential future partners.
Aurore Michelin
Articles by Aurore Michelin
R&D trends and breakthrough innovations: Chemical & material sustainability
This report identifies the latest trends in sustainable materials and green chemistry R&D, providing scientific decision-makers with a roadmap of high-impact opportunities, emerging technologies, and potential future partners.
Oncology R&D trends and breakthrough innovations
Explore the latest in oncology R&D with Inpart’s new trends report, featuring emerging technologies, breakthrough innovations, and expert insights shaping the future of cancer research.
Webinars 5 May 2025
AI in antibody discovery: From in silico analysis to AI-enabled data management
Explore how AI and bioinformatics are reshaping antibody discovery, from in silico design to efficient data management.
Whitepapers 28 Apr 2025
Function-focused single-cell analysis to accelerate antibody discovery
Discover how early functional screening at the single-cell level transforms therapeutic development of your antibodies.
R&D trends: Biotech assets & discovery platforms
Inpart’s latest report provides access to the most promising biotech assets and discovery platforms, shedding light on the latest trends in biotech R&D.
ADVERTISEMENT
ADVERTISEMENT
Partnering 2030: FME Industries Report
Download Inpart’s new report to discover key challenges in the Food, Material, and Electromechanical (FME) industries, the best channels for sourcing new partners, and a ranking of the top companies in industry-academia partnerships.
Partnering 2030: Biopharma Report
Download Inpart’s latest report to hear from biotechs and out-licensors, following this year’s Partnering 2030 survey. The report includes real-world partnering experiences, challenges, and insights into working with top pharmaceutical firms.
Antibody Therapy R&D trends and breakthrough innovations
Check out a new report exploring R&D trends and breakthrough innovations leveraging antibodies to create potentially game-changing therapies, published by our parent company Inpart.
Podcast 16 Aug 2024
Challenging the European biotech funding status quo
Explore the latest trends in biotech investments and funding strategies in Europe with insights from 4BIO Capital’s Dima Kuzmin.
Podcast 9 Aug 2024
Rebroadcast: Epigenetic editing – the power of CRISPR without cutting DNA
This week, we discuss epigenetic editing, why it’s reversible, treating FSHD and other conditions, with Epic Bio founder, Dr Stanley Qi.
Podcast 2 Aug 2024
Rebroadcast: How does AI assist drug discovery?
Listen to our podcast to discover how AI is revolutionizing drug discovery by tackling “undruggable” targets like KRAS.
ADVERTISEMENT
